There may be restrictions on sale in the destination (the U.S. for example where the FDA takes a dim view).
There may be export or import issues (would be the case for commercial quantities in Oz) and TGA issues here.
So you have a fairly highly taxed product as your cost base, quite likely added taxes in the destination and the likelihood that the product will be released in the destination at a lower price than your cost price.
